FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2037-2040 November 11, 2004 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Contamination problems in their British manufacturing facility at Speke, Liverpool, recently forced the Chiron Corporation of San Francisco, one of only two companies licensed to provide inactivated influenza vaccine in the United States, to withdraw their vaccine (Fluvirin) from the market. Currently, it appears that about 54 million doses of inactivated vaccine (Fluzone) will be available from the remaining manufacturer, Aventis, with another 1.1 million doses of intranasal live influenza vaccine (FluMist) available from MedImmune for use in healthy people 5 to 49 years of age. This represents about half the amount of vaccine expected for the 2004 vaccination campaign . . . [Full Text of this Article]

Source Information

From the Infectious Diseases Unit, University of Rochester Medical Center, Rochester, N.Y.

This article was published at www.nejm.org on October 18, 2004.

This article has been cited by other articles:

• Dhalla, I. A., Detsky, A. S. (2008). Risks and Benefits of Importing Prescription Medications From Lower-Income Countries. JAMA 300: 1453-1455 [Full Text]  
• Kornish, L. J., Keeney, R. L. (2008). Repeated Commit-or-Defer Decisions with a Deadline: The Influenza Vaccine Composition. Operations Research 56: 527-541 [Abstract]  
• Weiss, R. I., McKie, K. L., Goodman, R. A. (2007). The Law and Emergencies: Surveillance for Public Health-Related Legal Issues During Hurricanes Katrina and Rita. Am. J. Public Health 97: S73-S81 [Abstract] [Full Text]  
• Kramer, J. S., Durham, C., Schroeder, T., Garrelts, J. C. (2006). Effectiveness of half-dose versus full-dose influenza vaccine in health care workers.. Am J Health Syst Pharm 63: 2111-2115 [Abstract] [Full Text]  
• Rawlins, M. D (2005). Neglected diseases. BMJ 330: 376-377 [Full Text]